Rynek i konsumenci · 11/01/1995

FDA Extends Comment Period for Child-Resistant Packaging Rule for Naproxen Preparations

The US FDA has extended the comment period for a proposed rule requiring child-resistant packaging for naproxen preparations containing 250 mg or more of naproxen per package, originally set to close on January 30, 1995, and will now accept comments until March 1, 1995.